You are here

  • Home
  • Archive
  • Volume 73, Issue 6
  • Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension

Article metrics

Article menu

Download PDFPDF

Research letter
Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension

 

Online download statistics by month:

Online download statistics by month: October 2017 to March 2024

AbstractFullPdf
Oct 201715001547821
Nov 201712161267277
Dec 2017415414148
Jan 2018303304119
Feb 201827026093
Mar 2018289287122
Apr 201828028091
May 2018688690195
Jun 2018906919127
Jul 201823824074
Aug 201827027667
Sep 201823523791
Oct 201829329972
Nov 201826626765
Dec 201820220440
Jan 201923622768
Feb 201921621246
Mar 201924123265
Apr 201919818758
May 201919519148
Jun 201915615250
Jul 201912412142
Aug 201917016858
Sep 201916015757
Oct 201919318671
Nov 201915515571
Dec 201911911643
Jan 202017917573
Feb 202014414157
Mar 202015415275
Apr 202012312046
May 202012911552
Jun 202013512954
Jul 202013613448
Aug 202011511244
Sep 202017516939
Oct 202019417860
Nov 202017116748
Dec 202019718645
Jan 20211069937
Feb 202114213544
Mar 202116815953
Apr 202121621474
May 202114914744
Jun 202114714551
Jul 202112212160
Aug 202117017267
Sep 202112913237
Oct 202114013855
Nov 20211009954
Dec 202110210230
Jan 2022959027
Feb 202217216956
Mar 202220420357
Apr 202220420044
May 202220720763
Jun 202216816841
Jul 202215616055
Aug 202213013243
Sep 202213613464
Oct 202222222038
Nov 202218118451
Dec 202211712739
Jan 202323424151
Feb 202319920748
Mar 202316917343
Apr 202314314943
May 202318218247
Jun 202314815025
Jul 202317917548
Aug 202315416132
Sep 202312212823
Oct 202314014148
Nov 202321521455
Dec 202319117138
Jan 2024595921
Feb 202413713860
Mar 2024116116105
Total17457174355591